Literature DB >> 25342403

Select critically ill patients at risk of augmented renal clearance: experience in a Malaysian intensive care unit.

S Adnan1, S Ratnam2, S Kumar2, D Paterson3, J Lipman1, J Roberts1, A A Udy4.   

Abstract

Augmented renal clearance (ARC) refers to increased solute elimination by the kidneys. ARC has considerable implications for altered drug concentrations. The aims of this study were to describe the prevalence of ARC in a select cohort of patients admitted to a Malaysian intensive care unit (ICU) and to compare measured and calculated creatinine clearances in this group. Patients with an expected ICU stay of <24 hours plus an admission serum creatinine concentration <120 µmol/l, were enrolled from May to July 2013. Twenty-four hour urinary collections and serum creatinine concentrations were used to measure creatinine clearance. A total of 49 patients were included, with a median age of 34 years. Most study participants were male and admitted after trauma. Thirty-nine percent were found to have ARC. These patients were more commonly admitted in emergency (P=0.03), although no other covariants were identified as predicting ARC, likely due to the inclusion criteria and the study being under-powered. Significant imprecision was demonstrated when comparing calculated Cockcroft-Gault creatinine clearance (Crcl) and measured Crcl. Bias was larger in ARC patients, with Cockcroft-Gault Crcl being significantly lower than measured Crcl (P <0.01) and demonstrating poor correlation (rs=-0.04). In conclusion, critically ill patients with 'normal' serum creatinine concentrations have varied Crcl. Many are at risk of ARC, which may necessitate individualised drug dosing. Furthermore, significant bias and imprecision between calculated and measured Crcl exists, suggesting clinicians should carefully consider which method they employ in assessing renal function.

Entities:  

Keywords:  antibiotic dosing; augmented renal clearance; creatinine clearance; critical illness; glomerular filtration rate

Mesh:

Substances:

Year:  2014        PMID: 25342403     DOI: 10.1177/0310057X1404200606

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  13 in total

1.  Population Pharmacokinetics of Doripenem in Critically Ill Patients with Sepsis in a Malaysian Intensive Care Unit.

Authors:  Mohd H Abdul-Aziz; Azrin N Abd Rahman; Mohd-Basri Mat-Nor; Helmi Sulaiman; Steven C Wallis; Jeffrey Lipman; Jason A Roberts; Christine E Staatz
Journal:  Antimicrob Agents Chemother       Date:  2015-10-19       Impact factor: 5.191

2.  Urinary Creatinine Clearance and Pharmacokinetics Studies: If We Can Measure It, Why Do We Estimate It?

Authors:  Catarina M Silva; Andrew A Udy; João P Baptista
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

3.  Augmented renal clearance: a common condition in critically ill children.

Authors:  Tatjana Van Der Heggen; Evelyn Dhont; Harlinde Peperstraete; Joris R Delanghe; Johan Vande Walle; Peter De Paepe; Pieter A De Cock
Journal:  Pediatr Nephrol       Date:  2019-02-18       Impact factor: 3.714

4.  Augmented Renal Clearance in Critically Ill Patients: A Systematic Review.

Authors:  Idoia Bilbao-Meseguer; Alicia Rodríguez-Gascón; Helena Barrasa; Arantxazu Isla; María Ángeles Solinís
Journal:  Clin Pharmacokinet       Date:  2018-09       Impact factor: 6.447

5.  Augmented renal clearance in pediatric intensive care: are we undertreating our sickest patients?

Authors:  Evelyn Dhont; Tatjana Van Der Heggen; Annick De Jaeger; Johan Vande Walle; Peter De Paepe; Pieter A De Cock
Journal:  Pediatr Nephrol       Date:  2018-10-29       Impact factor: 3.714

Review 6.  Augmented Renal Clearance in Critical Illness: An Important Consideration in Drug Dosing.

Authors:  Sherif Hanafy Mahmoud; Chen Shen
Journal:  Pharmaceutics       Date:  2017-09-16       Impact factor: 6.321

7.  β-Lactam Dosage Regimens in Septic Patients with Augmented Renal Clearance.

Authors:  Alexandra Jacobs; Fabio Silvio Taccone; Jason A Roberts; Frédérique Jacobs; Frederic Cotton; Fleur Wolff; Jacques Creteur; Jean-Louis Vincent; Maya Hites
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

8.  Development of a decision flowchart to identify the patients need high-dose vancomycin in early phase of treatment.

Authors:  Ryo Yamaguchi; Hiroko Kani; Takehito Yamamoto; Takehiro Tanaka; Hiroshi Suzuki
Journal:  J Pharm Health Care Sci       Date:  2022-01-04

Review 9.  Prevalence and Risk Factors of Augmented Renal Clearance: A Systematic Review and Meta-Analysis.

Authors:  Fatma Hefny; Anna Stuart; Janice Y Kung; Sherif Hanafy Mahmoud
Journal:  Pharmaceutics       Date:  2022-02-19       Impact factor: 6.321

10.  Augmented renal clearance is not a risk factor for mortality in Enterobacteriaceae bloodstream infections treated with appropriate empiric antimicrobials.

Authors:  Jason P Burnham; Scott T Micek; Marin H Kollef
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.